Cargando…

Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity

Tamoxifen is administered for estrogen receptor positive (ER(+)) breast cancers, but it can induce uterine endometrial cancer and non-alcoholic fatty liver disease (NAFLD). Importantly, ten years of tamoxifen treatment has greater protective effect against ER(+) breast cancer than five years of such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Wenwen, Xu, Wenping, Sun, Xiaoxi, Zeng, Bubing, Wang, Shuangjie, Dong, Nian, Zhang, Xu, Chen, Chengshui, Yang, Long, Chen, Guowu, Xin, Aijie, Ni, Zhong, Wang, Jian, Yang, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5339706/ https://www.ncbi.nlm.nih.gov/pubmed/28266626 http://dx.doi.org/10.1038/srep43940

Ejemplares similares

Tamoxifen side effects: pharmacogenetic and clinical approach in Mexican mestizos
por: Rangel-Méndez, Jorge-Aarón, et al.
Publicado: (2019)

Integrins β1 and β3 are biomarkers of uterine condition for embryo transfer
por: Chen, Guowu, et al.
Publicado: (2016)

Nanoformulation improves antitumor efficacy of MAOI immune checkpoint blockade therapy without causing aggression-related side effects
por: Brown, James, et al.
Publicado: (2022)

Resuming Sensitivity of Tamoxifen-Resistant Breast Cancer Cells to Tamoxifen by Tetrandrine
por: Wang, Yuntao, et al.
Publicado: (2021)

Transporting Antitumor Drug Tamoxifen and Its Metabolites, 4-Hydroxytamoxifen and Endoxifen by Chitosan Nanoparticles
por: Agudelo, Daniel, et al.
Publicado: (2013)

CBD-oil as a potential solution in case of severe tamoxifen-related side effects
por: Buijs, Sanne M., et al.
Publicado: (2023)

Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side study
por: van Nes, J. G. H., et al.
Publicado: (2012)

Disruption in ACTL7A causes acrosomal ultrastructural defects in human and mouse sperm as a novel male factor inducing early embryonic arrest
por: Xin, Aijie, et al.
Publicado: (2020)

Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines
por: Kalabay, Márton, et al.
Publicado: (2022)

Huaier extract synergizes with tamoxifen to induce autophagy and apoptosis in ER-positive breast cancer cells
por: Qi, Wenwen, et al.
Publicado: (2016)

AFF3 upregulation mediates tamoxifen resistance in breast cancers
por: Shi, Yawei, et al.
Publicado: (2018)

Natural killer cells strengthen antitumor activity of cisplatin by immunomodulation and ameliorate cisplatin-induced side effects
por: Wang, Zhu, et al.
Publicado: (2023)

Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review
por: Hind, D, et al.
Publicado: (2007)

Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen
por: Hussaarts, Koen G.A.M., et al.
Publicado: (2019)

Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy
por: Chang, Xindi, et al.
Publicado: (2023)

The impact of endoxifen-guided tamoxifen dose reductions on endocrine side-effects in patients with primary breast cancer
por: Buijs, S.M., et al.
Publicado: (2023)

Andrographolide-loaded silk fibroin nanoparticles
por: Zhongyu, Xu, et al.
Publicado: (2018)

Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer
por: Huang, Shuai, et al.
Publicado: (2019)

CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects
por: Dezentjé, V. O., et al.
Publicado: (2015)

Adverse Events as a Potential Clinical Marker of Antitumor Efficacy in Ovarian Cancer Patients Treated With Poly ADP-Ribose Polymerase Inhibitor
por: Ni, Jing, et al.
Publicado: (2021)

Caffeine Modulates the Antitumor Activity and Toxic Side Effects of Adriamycin
por: Sadzuka, Yasuyuki, et al.
Publicado: (1993)

IARC on tamoxifen.
Publicado: (1996)

Tamoxifen evolution
por: Howell, A., et al.
Publicado: (2023)

A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells
por: Meng, Du, et al.
Publicado: (2019)

Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells
por: Stella, Stefania, et al.
Publicado: (2023)

Targeted elimination of senescent cells by engineered extracellular vesicles attenuates atherosclerosis in ApoE(-/-) mice with minimal side effects
por: Zhang, Liang, et al.
Publicado: (2023)

Acute Pancreatitis Caused by Tamoxifen-Induced Severe Hypertriglyceridemia After 4 Years of Tamoxifen Use
por: Tey, Tze Tong, et al.
Publicado: (2019)

The response of anti-VEGF therapy and tamoxifen withdrawal of tamoxifen-induced cystoid macular edema in the same patient
por: Li, Chuanyu, et al.
Publicado: (2021)

Potential risk of tamoxifen: gut microbiota and inflammation in mice with breast cancer
por: Li, Hailong, et al.
Publicado: (2023)

Antitumor efficacy of combined CTLA4/PD-1 blockade without intestinal inflammation is achieved by elimination of FcγR interactions
por: Bauché, David, et al.
Publicado: (2020)

Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis
por: Hou, Guo-Xin, et al.
Publicado: (2018)

Cisplatin‐incorporated Polymeric Micelles Eliminate Nephrotoxicity, While Maintaining Antitumor Activity
por: Mizumura, Yasuo, et al.
Publicado: (2001)

Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
por: Xu, Zhixiao, et al.
Publicado: (2021)

The Downregulation of PTGS2 Mediated by ncRNAs is Tightly Correlated with Systemic Sclerosis-Interstitial Lung Disease
por: Xu, Zhixiao, et al.
Publicado: (2022)

Potential Therapeutic Benefit of Combining Gefitinib and Tamoxifen for Treating Advanced Lung Adenocarcinoma
por: Liu, Chien-Ming, et al.
Publicado: (2015)

lncRNA MAGI2‐AS3 overexpression had antitumor effect on Hepatic cancer via miRNA‐23a‐3p/PTEN axis
por: Liu, Fei, et al.
Publicado: (2021)

HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer
por: Xue, Yue, et al.
Publicado: (2019)

Impact of Irradiation on the Pharmacokinetics and Biotransformation of Tamoxifen
por: Cheng, Yung-Yi, et al.
Publicado: (2022)

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Epithelial-mesenchymal transition is associated with osteopontin-induced EGFR‑TKI resistance in EGFR mutant non-small cell lung cancer
por: Chen, Junjie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a53rsfs9ebecdjc5guje2sha5k